Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-24 @ 11:57 PM
NCT ID:
NCT04364451
Eligibility Criteria:
Inclusion Criteria:
Children and adolescents newly diagnosed with acute lymphoblastic leukaemia. A complete personal and family history will be recorded for each participant from every group with particular emphasis on the presence of dyslipidaemia, early cardiovascular disease or cerebrovascular accident in the individual or in the family. A thorough clinical examination will be performed and the vital signs, blood pressure, weight (kg), height (m) and a Body/Mass Index (BMI) will be recorded and calculate.
The Exclusion criteria are the following:
* Thyroid Disorder (Abnormal thyroid function)
* Familial Hypercholesterolemia
* High Body/ Mass Index (BMI)
* Administration of corticosteroids some time during the past 2 weeks before diagnosis
* Administration of total parenteral nutrition before the diagnosis
* Administration of plasma before the diagnosis
* Changes or variation of the parameters under study before the start of treatment and the 11th day (before the start of asparagine administration).
Healthy Volunteers:
True
Sex:
ALL
Maximum Age:
16 Years
Study:
NCT04364451
Study Brief:
Protocol Section:
NCT04364451